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Overview
• Before Apollo fire, early Apollo missions were expected to continue 
pattern established in Gemini program of accommodating significant 
scientific and biological experimentation, including human biomedical 
studies, during flights
• Apollo 1 and Apollo 2, both 2-week engineering test flights, were to carry 
almost as many biomedical studies as Gemini 7, a 2-week medical test 
mission
NASA Headquarters position on in-flight science
(June 1965)
“Although the principal objective of Apollo is to land 
astronauts on the lunar surface (...), we are also performing 
considerable in-flight experimentation as well, particularly on 
the developmental flights leading up to the lunar landing. 
Some of these are experiments to determine man’s physical 
functioning in space and the medical effects of the space 
environment on man. These investigations contribute 
directly to the lunar landing capability. However, we will also 
perform other medical inflight experiments whose purpose
is to add to the store of man’s knowledge. (...) Many important scientific investigations in 
the fields of biology, physics and astronomy are also included in the Apollo Program.”
Samuel C. Phillips, Brig. Gen., USAF, Director of the Apollo Program, memo dated June 30, 1965, to Dr. 
George E. Mueller, Assoc. Admin. for Manned Space Flight, “Points for the Wood’s Hole Talk”
NASA Manned Spacecraft Center position on in-flight 
science (May 1965)
“The main goal of the early Apollo Earth orbital missions is the 
certification of the spacecraft design and development of 
operational procedures for the lunar landing mission. The 
program policy is also, to accommodate, whenever possible, 
significant in-flight experiments. [...] Although the ground rule 
has been that [these] experiments will be carried out on a 
‘noninterference’ basis, each added requirement interferes, 
hopefully to only a small degree, with the main task of early 
development of the lunar system. For this reason, the
experiments to be flown on the Earth orbital Apollo missions should meet one of the 
following criteria:
1. Contribute directly to the body of data needed for the lunar mission; and
2. Be of such importance to the scientific community that deferral to later Apollo flights 
is clearly undesirable.”
Dr. Robert Gilruth, director of MSC, memo dated May 5, 1965, to Dr. George E. Mueller, NASA Assoc. 
Admin. for Manned Space Flight, “Reassignment of Apollo onboard experiments.”
The Apollo Program in early 1966
Date Mission Duration Objectives
January 1966 AS-201 Test Block 1 CSM, Saturn IB unmanned
June 1966 AS-203 Test Block 1 CSM, Saturn IB unmanned
July 1966 AS-202 Test S-IVB stage to destruction
October 1966 AS-204, Apollo 1 14 days 1st manned test flight
December 1966 AS-205, Apollo 2 14 days 2nd manned test flight
December 1966 AS-501 Test Saturn V unmanned
March 1967 AS-206 Test LM unmanned
April 1967 AS-502 Test Saturn V unmanned
June 1967 AS-207/208, Apollo 3 10 days 1st manned Block 2 CSM, LM test flight
September 1967 AS-503, Apollo 4 8-10 days 1st manned Saturn V; LM test in LEO
January 1968 AS-504, Apollo 5 8 days Manned lunar mission simulation in HEO
April 1968 AS-505, Apollo 6 8 days Possible first manned lunar landing
Comparison of General Mission Characteristics of 
Apollo 1 and  Apollo 2 (as of September 1965)
Mission Apollo 1 (AS-204) Apollo 2 (AS-205)
Spacecraft CSM-012, LES-12, SLA-5 CSM-014, LES-14, SLA-6
Launch date Early 1967 Mid-1967
Maximum 
duration
13.8 days 13.8 days
SPS firings 8 4
Primary 
objectives
1. Verify spacecraft/crew operations
2. Determine CSM subsystem performance
3. Evaluate S-IVB and IU checkout in orbit
4. Demonstrate S-IVB attitude control
5. Demonstrate crew/CSM/launch 
vehicle/mission support facilities performance
Same as Apollo 1 plus:
1. CSM/S-IVB maneuvering for IMU alignment, tracking of 
stars and earth landmarks
2. CSM transposition, simulated docking with S-IVB
3. Separation, re-rendezvous, simulated docking
4. S-IVB LH2 venting (6 times) and LO2 venting (twice)
Secondary 
objectives
11 experiments
5 medical (1 pre/post only)
4 scientific
1 technological
15 experiments
8 medical
7 scientific
Gemini and Planned Apollo Biomedical Experiments (January 1966)
Experiment
Gemini 4
4 days
2 men
Gemini 5
8 days
2 men
Gemini 7
14 days
2 men
Apollo 1
14 days
3 men
Apollo 2
14 days
3 men
M-1 Cardiovascular Deconditioning ✔ ✔
M-3 In-flight Exerciser ✔ ✔ ✔ X
M-4 In-flight Phonocardiogram ✔ ✔ ✔ X
M-5 Bioassays Body Fluids ✔ ✔ X X
M-6 Bone Demineralization ✔ ✔ X X
M-7 Calcium Balance ✔ X
M-9 Human Otolith Function ✔ ✔ X X
M-12 Exercise Ergometer X X
M-20 Pulmonary Function X
T-3 In-flight Nephelometer X
T-4/S-14 Frog Otolith Experiment X
S-15 Zero G Single Human Cells X
S-16 Trapped Particle Asymmetry X
Evolution of Planned Apollo 1 Biomedical Experiments
Experiment May 1965
June 
1965
Aug 
1965
Sep 
1965
Jan 
1966
June 
1966
Sep 
1966
M-1 Cardiovascular Deconditioning X X X X
M-3 In-flight Exerciser X X X
M-4 In-flight Phonocardiogram X X X X X
M-5 Bioassays Body Fluids X X X X X
M-6 Bone Demineralization X X X X X X X
M-7 Calcium Balance
M-9 Human Otolith Function X X X X X X X
M-12 Exercise Ergometer X X X X X
M-17 Thoracic Blood Flow X
M-18 Vectorcardiogram X
M-19 Metabolic Rate Measurement X
M-20 Pulmonary Function X
M-48 Cardiovascular Reflex Deconditioning X X
T-3 In-flight Nephelometer X X X
Evolution of Planned Apollo 2 Biomedical Experiments
Experiment May 1965
Aug 
1965
Jan 
1966
Apr 
1966
Aug 
1966
M-4 In-flight Phonocardiogram X X X X
M-5A Bioassays Body Fluids X X
M-6 Bone Demineralization X X X X X
M-7 Calcium Balance X X X X X
M-9 Human Otolith Function X X X X
M-11 Cytogenic Blood Studies X X X X
M-12 Exercise Ergometer X X X X X
M-19 Metabolic Rate Measurement X X X X
M-20 Pulmonary Function X X X X X
M-23 Lower Body Negative Pressure X X
T-4/S-14 Frog Otolith Experiment X X X X X
S-15 Zero G Single Human Cells X X X X X
S-16 Trapped Particle Asymmetry X X X X X
The Apollo Program in late 1966
Date Mission Duration Objectives
February 1967 AS-204, Apollo 1 14 days 1st manned test flight
December 1966 AS-205, Apollo 2 14 days 2nd manned test flight
~April 1967 AS-501 Test Saturn V unmanned
~July 1967 AS-206 Test LM unmanned
~August 1967 AS-502 Test Saturn V unmanned
~October 1967 AS-205/208, Apollo 2 10 days 1st manned Block 2 CSM, LM test flight
1968 AS-503, Apollo 4 8-10 days 1st manned Saturn V; LM test in LEO
1968 AS-504, Apollo 5 8 days Manned lunar mission simulation in HEO
1968 AS-505, Apollo 6 8 days Possible first manned lunar landing
Evolution of Biomedical Experiments Planned For Apollo 3 (AS-207/208), later (after Nov. 1966) Apollo 2 (AS-205/208)
Experiment May1965
Aug.
1965
Dec.
1965
Mar.
1966
Apr.
1966
Aug.
1966
Nov.
1966
M-3A In-flight Exerciser NF
M-4A In-flight Phonocardiogram (X)
M-5A Bioassays Body Fluids X X
M-6A Bone Demineralization* X X
M-8 In-flight Sleep Analysis (X)
M-9 Human Otolith Function (X)
M-11 Cytogenic Blood Studies X X
M-12 In-flight Ergometer (X)
M-17 Thoracic Blood Flow (X) NF
M-18 Vectorcardiogram (X) NF
M-22 Red Blood Cell Survival (X)
M-23 Lower Body Negative Pressure* X X X X X
T-3 In-flight Nephelometer X
D-8A Radiation in Spacecraft X X X X X X X
( ) under consideration
NF evaluated but judged 
not feasible
*  pre- and postflight only
X [bold] explicit
X inferred
After the Apollo Fire: biomedical data
Crew health and inflight monitoring
• Clinical care
• Microbial investigations
• Radiation monitoring
• Metabolism and heat dissipation
• Environmental factors
• Toxicology
Pre/postflight medical testing
• Endocrine, electrolyte and fluid 
volume changes
• Clinical biochemistry
• Hematology and immunology
• Cardiovascular assessment
• Exercise responses
• Nutritional studies
• Skeletal response
• Vestibular assessment
Biomedical Results of Apollo
Johnston, Dietlein and Berry
NASA SP-368, 1975
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Apollo experiment Skylab experiment
M-5 Bioassays Body Fluids M073 Bioassay of Body Fluids
M-11 Cytogenic Blood Studies M111 Cytogenic Blood Studies
M-22 Red Blood Cell Survival M110 Hematology, Immunology
M-6 Bone Demineralization M078 Bone Mineral Measurement
M-7 Calcium Balance M071 Mineral Balance
M-8 In-flight Sleep Analysis M133 Sleep Monitoring
M-9 Human Otolith Function M131 Human Vestibular Function
M-18 Vectorcardiogram
M093 Vectorcardiogram(M-4 In-flight Phonocardiogram)
(M-17 Thoracic Blood Flow)
M-19 Metabolic Rate Measurement
M171 Metabolic Activity
M-20 Pulmonary Function
M-12 Exercise Ergometer
(M-3 In-flight Exerciser)
M-23 Lower Body Negative Pressure
M092 Lower Body Negative Pressure(M-48 Cardiovascular Reflex Conditioning)
(M-1 Cardiovascular Deconditioning)
( ): subsumed 
or OBE
Biomedical 
Results from 
Skylab
Johnston and 
Dietlein
NASA SP-377, 
1977
S-15, Zero G 
Single Human 
Cells
S015, The 
Response of Single 
Human Cells to 
Zero- Gravity
After the Apollo Fire: biological experiments
• Weightlessness
• Frog Otolith Experiment
• demanifested from Apollo 
program
• added to OWS Airlock Module 
(AAP-2) in June 1967
• transferred to AAP-1A—cancelled 
June 1968
• flew as Orbiting Frog Otolith, 
launched by a Scout rocket into 
LEO Nov. 9, 1970. 
• Functioned for over 6 days, frogs 
acclimated after ~ 5 days
After the Apollo Fire: biological experiments
• Space Radiation
• BIOSTACK (Apollo 16 
and 17): spores, seeds, 
animal eggs
• Apollo Light Flash 
Investigation (Apollo 14, 
15, 16 and 17)
• Microbial Response to 
Space Environment 
Experiment (Apollo 16)
• BIOCORE Pocket Mouse 
Experiment (Apollo 17)
Results
• After Apollo fire, early Apollo missions were scrubbed of all in-flight biomedical experiments, 
other non-operational evaluations
• Prioritized checkouts of spacecraft components to accomplish manned lunar landing, safe 
return
• After goal was attained and sufficient confidence had been established in spacecraft functionality, 
small number of human and biological experiments were accommodated
• However, even earliest Apollo missions flown saw extensive pre- and postflight biomedical studies 
in support of operational medical certification of astronaut capacity for substantial workloads of 
lunar surface
• Apollo lunar surface crewmembers were sparsely instrumented but creatively monitored using 
data provided by their life support systems 
• Biomedical, biological research deferred from Apollo were largely acquired on Skylab under well-
controlled circumstances with larger number of crewmen participants
• These data formed basis for more intensive studies on Space Shuttle, established foundation for 
continuing investigations on International Space Station
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